EBGI Category: Pregnancy
-
Ustekinumab and Vedolizumab Demonstrate Safety During Pregnancy: Updates from the PIANO Registry
American College of Gastroenterology / EBGI Articles / IBD / Ustekinumab and Vedolizumab Demonstrate Safety During Pregnancy: Updates from the PIANO RegistryUstekinumab and Vedolizumab Demonstrate Safety During Pregnancy-Updates From the PIANO Registry Rahul Dalal, MD, MPH Instructor, Division of Gastroenterology, Hepatology,…
-
Continuing Anti-TNF Agents past 24 Weeks of Pregnancy Associated with Fewer IBD Relapses with No Increase in Adverse Fetal Outcomes
American College of Gastroenterology / EBGI Articles / IBD / Continuing Anti-TNF Agents past 24 Weeks of Pregnancy Associated with Fewer IBD Relapses with No Increase in Adverse Fetal OutcomesContinuing Anti-TNF Agents Past 24 Weeks of Pregnancy Associated with Fewer IBD Relapses with No Increase in Adverse Fetal Outcomes…
-
Continue Thiopurines and Anti-TNF Agents If Your IBD Patient Becomes Pregnant
American College of Gastroenterology / EBGI Articles / IBD / Continue Thiopurines and Anti-TNF Agents If Your IBD Patient Becomes PregnantContinue Thiopurines and Anti-TNF Agents If Your IBD Patient Becomes Pregnant: Results from the Pregnancy in IBD and Neonatal Outcomes…
-
Achieve IBD Remission Before Pregnancy
Achieve IBD Remission Before Pregnancy: PIANO Registry Data Shows Adverse Perinatal Outcomes For Infants Associated with IBD Flares and Steroid…